The Present Status of Trachoma Vaccination Studies

Overview

Journal Bull World Health Organ

Specialty Public Health

Date 1966 Jan 1

PMID 5296129

Citations 5

Authors

L H Collier

Affiliations

Soon will be listed here.

Abstract

The control of trachoma is still an outstanding problem for many developing countries, despite the widespread use of antibiotics both for prevention and treatment. The isolation of the causal agent in 1957 gave hope of developing a prophylactic vaccine, and in recent years much research has been done on this subject. This article summarizes the requirements that have to be met by a trachoma vaccine and problems arising in its manufacture and testing. A review of the progress made by various workers in this field suggests that, although some vaccines now being tested are partially effective, much remains to be learned about immunity to trachoma and methods of inducing it artificially.

Citing Articles

Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers.

Inic-Kanada A, Stojanovic M, Schlacher S, Stein E, Belij-Rammerstorfer S, Marinkovic E PLoS One. 2015; 10(12):e0144380.

PMID: 26656797 PMC: 4684359. DOI: 10.1371/journal.pone.0144380.

A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates.

Kari L, Whitmire W, Olivares-Zavaleta N, Goheen M, Taylor L, Carlson J J Exp Med. 2011; 208(11):2217-23.

PMID: 21987657 PMC: 3201208. DOI: 10.1084/jem.20111266.

Immunogenicity of experimental trachoma vaccines in baboons: III. Experiments with inactivated vaccines.

Collier L, Blyth W, Larin N, Treharne J J Hyg (Lond). 2010; 65(1):97-107.

PMID: 20475873 PMC: 2130175. DOI: 10.1017/s0022172400045575.

Trachoma vaccine field trials in The Gambia.

Sowa S, Sowa J, Collier L, Blyth W J Hyg (Lond). 1969; 67(4):699-717.

PMID: 5261212 PMC: 2130770. DOI: 10.1017/s0022172400042157.

Immunogenicity of experimental trachoma vaccines in baboons. I. Experimental methods, and preliminary tests with vaccines prepared in chick embryos and in HeLa cells.

Collier L, Blyth W J Hyg (Lond). 1966; 64(4):513-28.

PMID: 4959126 PMC: 2134757. DOI: 10.1017/s0022172400040821.

References

GRAYSTON J, WOOLRIDGE R, Wang S, Yen C, Yang C, Cheng K . Field studies of protection from infection by experimental trachoma virus vaccine in preschool-aged children on Taiwan. Proc Soc Exp Biol Med. 1963; 112:589-95. DOI: 10.3181/00379727-112-28112. View

Collier L . Trachoma and allied infections. Trans Ophthalmol Soc U K (1962). 1961; 81:351-65. View

Wang S, GRAYSTON J . CLASSIFICATION OF TRACHOMA VIRUS STRAINS BY PROTECTION OF MICE FROM TOXIC DEATH. J Immunol. 1963; 90:849-56. View

GRAYSTON J, Wang S, WOOLRIDGE R, ALEXANDER E . PREVENTION OF TRACHOMA WITH VACCINE. Arch Environ Health. 1964; 8:518-26. DOI: 10.1080/00039896.1964.10663711. View

GARCIA GANCEDO A, Felici A, VOZZA R . [Serological research on trachoma]. Boll Ocul. 1961; 40:721-34. View

Parikh G, SHECHMEISTER I . INTERACTION OF MENINGOPNEUMONITIS VIRUS WITH WHITE BLOOD CELLS. II. ANTIGENIC SUBUNITS OF MENINGOPNEUMONITIS VIRUS. Virology. 1964; 22:177-85. DOI: 10.1016/0042-6822(64)90002-9. View

Reeve P, Taverne J . A simple method for total particle counts of trachoma and inclusion blennorrhoea viruses. Nature. 1962; 195:923-4. DOI: 10.1038/195923a0. View

Reeve P, Graham D . A neutralization test for trachoma and inclusion blennorrhoea viruses grown in HeLa cell cultures. J Gen Microbiol. 1962; 27:177-80. DOI: 10.1099/00221287-27-1-177. View

Furness G, Graham D, Reeve P . The titration of trachoma and inclusion blennorrhoea viruses in cell cultures. J Gen Microbiol. 1960; 23:613-9. DOI: 10.1099/00221287-23-3-613. View

10.

BERNKOPF H, Nishmi M, MAYTHAR B, FEITELBERG I . Darkfield agglutination of fluorocarbon-treated trachoma virus by serums of trachoma patients and immunized rabbits. J Infect Dis. 1960; 106:83-6. DOI: 10.1093/infdis/106.1.83. View

11.

Collier L, DUKE-ELDER S, Jones B . Experimental trachoma produced by cultured virus. Br J Ophthalmol. 1958; 42(12):705-20. PMC: 509741. DOI: 10.1136/bjo.42.12.705. View

12.

BELL Jr S, MURRAY E, Carroll T, Snyder J . STUDIES ON TRACHOMA. III. COMPARISON OF VIRUS INFECTIVITY FOR MAN AND CHICK EMBRYOS. Am J Trop Med Hyg. 1963; 12:902-8. View

13.

BERNKOPF H . The susceptibility of white mice to a strain of trachoma virus and their use in neutralization tests. Bull Res Counc Isr Sect E Exp Med. 1959; 8E:25-9. View

14.

BELL Jr S, Nichols R, HADDAD N . THE IMMUNOLOGY OF THE TRACHOMA AGENT WITH A PRELIMINARY REPORT ON FIELD TRIALS ON VACCINE. Invest Ophthalmol. 1963; 2:471-81. View

15.

Felici A, VOZZA R . [Virological research on trachoma. Preliminary data]. Rend Ist Sup Sanit. 1960; 23:1242-75. View

16.

Nichols R, McComb D . SEROLOGIC STRAIN DIFFERENTIATION IN TRACHOMA. J Exp Med. 1964; 120:639-54. PMC: 2137777. DOI: 10.1084/jem.120.4.639. View

17.

GRAYSTON J, Wang S, Yang Y, WOOLRIDGE R . The effect of trachoma virus vaccine on the course of experimental trachoma infection in blind human volunteers. J Exp Med. 1962; 115:1009-22. PMC: 2137531. DOI: 10.1084/jem.115.5.1009. View

18.

BELL Jr S, Theobald B . Differentiation of trachoma strains on the basis of immunization against toxic death of mice. Ann N Y Acad Sci. 1962; 98:337-46. DOI: 10.1111/j.1749-6632.1962.tb30556.x. View

19.

Reeve P, Taverne J . Observatios on the growth of trachoma and inclusion blennorrhoea viruses in embryonate eggs. J Hyg (Lond). 1963; 61:67-75. PMC: 2134542. DOI: 10.1017/s0022172400020751. View

20.

Scott J . Experience with live trachoma vaccine. Trans Ophthalmol Soc U K (1962). 1964; 84:615-24. View